Inflammatory Biomarkers as Predictors of PONV Following Pediatric Orchiopexy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-8
SponsorDiskapi Yildirim Beyazit Education and Research Hospital
About this trial
Orchiopexy is a common surgical procedure for the treatment of cryptorchidism in the pediatric population, with a high incidence of postoperative nausea and vomiting (PONV).
Recent evidence suggests that systemic inflammation may contribute to PONV pathogenesis, and preoperative inflammatory biomarkers such as NLR, PLR, SII, MLR, and SIRI could serve as predictive indicators.
This prospective observational study aims to evaluate the relationship between these biomarkers and PONV incidence in children undergoing orchiopexy.
Eligibility criteria
Qualifiers
Patients aged between 1 and 8 years
Patients with ASA physical status I-II
Patients scheduled for elective orchiopexy
Obtained written informed consent from parents/guardians
Disqualifiers
Patients younger than 1 year or older than 8 years
Patients with ASA physical status III or higher
Presence of acute infection signs
History of previous nausea or vomiting
Trial design
Treatments tested in this trial
- Measurement of Preoperative Inflammatory Biomarkers
Treatment groups
No treatment groups listed
Sponsors and collaborators
Diskapi Yildirim Beyazit Education and Research Hospital
Lead sponsor
Ankara Etlik City Hospital
Sponsor institution
Source ClinicalTrials.gov